Skip to main content
OpenTrials
Completed

NCT Number: NCT01281215

Education Interventions Model for Rational Drug Use (RDU)

The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Hospital of Medicine Faculty of Ribeirão Preto, University of São Paolo

Ribeirão Preto, São Paulo, 14048-800, Brazil

About this study

Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject with asthma diagnosed according to criteria of the Global Strategy for Asthma Management and Prevention;
  • Subject is a male or female with 18 to 73 years-old;
  • Subject who has access to medications supplied by the the Brazil Heath Care System;
  • Subject unable to perform the procedures or conditions such as pregnancy that may affect the results of the study;
  • Literate subject without Cognitive Disorders, Alzheimer's, Dementia, that can limit the ability to participate in this study;
  • Subject who have availability to attend the monthly meetings;
  • Subject provides written informed consent and attend the first evaluation.

Exclusion criteria

  • Subject who cannot be classified in the inclusion criteria.

Treatment and study plan

Education interventional

Behavioral

The patients will receive pharmaceutical education to know more about asthma, the importance of treatment compliance, the medications used to control the pathology, corrected patients' inhalation techniques and the medication care.

Other names: Pharmaceutical Care

Primary outcomes

  1. Knowledge of Asthma

    Time frame: 6 months after the first evaluation

    To compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire.

Secondary outcomes

  1. Spirometry Exam

    Time frame: 6 months after the first evaluation

    To compare the patient´s pulmonary function before and after the education interventions with spirometry exam.

  2. Sociodemographic data, clinical and lifestyle evaluation

    Time frame: 6 months after the first evaluation

    To evaluate the sociodemographic data, clinical and lifestyle before and after the education interventions and its impact on the quality of life.

  3. Management of inhalers

    Time frame: 6 months after the first evaluation

    To evaluate the technique for using inhalation devices among asthma patients before and after education interventions. Patients will be asked to demonstrate their inhaler technique.

  4. Treatment compliance evaluation

    Time frame: 6 months after the first evaluation

    To evaluate the treatment compliance with Morisky&Green test and pharmacy database query before and after educations interventions.

  5. Economic analysis

    Time frame: 6 months after the first evaluation

    Economic analysis after the model implementation.

  6. Quality of Life Evaluation

    Time frame: 6 months after the first evaluation

    To compare the Quality of Life before and after the education interventions

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Registry information

Official study title

Education Interventions Model for Rational Drug Use

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jan 21, 2011
Registry last updated
Oct 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.